These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 21697009

  • 1. Melanin concentrating hormone in central hypersomnia.
    Peyron C, Valentin F, Bayard S, Hanriot L, Bedetti C, Rousset B, Luppi PH, Dauvilliers Y.
    Sleep Med; 2011 Sep; 12(8):768-72. PubMed ID: 21697009
    [Abstract] [Full Text] [Related]

  • 2. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S, Kanbayashi T.
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [Abstract] [Full Text] [Related]

  • 3. Normal Morning Melanin-Concentrating Hormone Levels and No Association with Rapid Eye Movement or Non-Rapid Eye Movement Sleep Parameters in Narcolepsy Type 1 and Type 2.
    Schrölkamp M, Jennum PJ, Gammeltoft S, Holm A, Kornum BR, Knudsen S.
    J Clin Sleep Med; 2017 Feb 15; 13(2):235-243. PubMed ID: 27855741
    [Abstract] [Full Text] [Related]

  • 4. [Narcolepsy--new implications of molecular biology].
    Knudsen S, Jennum PJ.
    Ugeskr Laeger; 2006 Oct 23; 168(43):3699-704. PubMed ID: 17069732
    [Abstract] [Full Text] [Related]

  • 5. Relationship between clinical characteristics of narcolepsy and CSF orexin-A levels.
    Nakamura M, Kanbayashi T, Sugiura T, Inoue Y.
    J Sleep Res; 2011 Mar 23; 20(1 Pt 1):45-9. PubMed ID: 20642748
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Normal CSF hypocretin-1 (orexin A) levels in dementia with Lewy bodies associated with excessive daytime sleepiness.
    Baumann CR, Dauvilliers Y, Mignot E, Bassetti CL.
    Eur Neurol; 2004 Mar 23; 52(2):73-6. PubMed ID: 15256827
    [Abstract] [Full Text] [Related]

  • 8. Hypocretin deficiency in narcolepsy with cataplexy is associated with a normal body core temperature modulation.
    Grimaldi D, Agati P, Pierangeli G, Franceschini C, Guaraldi P, Barletta G, Vandi S, Cevoli S, Plazzi G, Montagna P, Cortelli P.
    Chronobiol Int; 2010 Sep 23; 27(8):1596-608. PubMed ID: 20854137
    [Abstract] [Full Text] [Related]

  • 9. The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A).
    Bassetti C, Gugger M, Bischof M, Mathis J, Sturzenegger C, Werth E, Radanov B, Ripley B, Nishino S, Mignot E.
    Sleep Med; 2003 Jan 23; 4(1):7-12. PubMed ID: 14592354
    [Abstract] [Full Text] [Related]

  • 10. Multiple sleep latency measures in narcolepsy and behaviourally induced insufficient sleep syndrome.
    Marti I, Valko PO, Khatami R, Bassetti CL, Baumann CR.
    Sleep Med; 2009 Dec 23; 10(10):1146-50. PubMed ID: 19464232
    [Abstract] [Full Text] [Related]

  • 11. Association between the activation of MCH and orexin immunorective neurons and REM sleep architecture during REM rebound after a three day long REM deprivation.
    Kitka T, Adori C, Katai Z, Vas S, Molnar E, Papp RS, Toth ZE, Bagdy G.
    Neurochem Int; 2011 Oct 23; 59(5):686-94. PubMed ID: 21740944
    [Abstract] [Full Text] [Related]

  • 12. Parkinsonism with excessive daytime sleepiness--a narcolepsy-like disorder?
    Baumann C, Ferini-Strambi L, Waldvogel D, Werth E, Bassetti CL.
    J Neurol; 2005 Feb 23; 252(2):139-45. PubMed ID: 15729517
    [Abstract] [Full Text] [Related]

  • 13. Normal cerebrospinal fluid levels of hypocretin-1 (orexin A) in patients with fibromyalgia syndrome.
    Taiwo OB, Russell IJ, Mignot E, Lin L, Michalek JE, Haynes W, Xiao Y, Zeitzer JM, Larson AA.
    Sleep Med; 2007 Apr 23; 8(3):260-5. PubMed ID: 17369087
    [Abstract] [Full Text] [Related]

  • 14. Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy.
    Baumann CR, Khatami R, Werth E, Bassetti CL.
    J Neurol Neurosurg Psychiatry; 2006 Mar 23; 77(3):402-4. PubMed ID: 16484654
    [Abstract] [Full Text] [Related]

  • 15. Narcolepsy in Parkinson's disease.
    Haq IZ, Naidu Y, Reddy P, Chaudhuri KR.
    Expert Rev Neurother; 2010 Jun 23; 10(6):879-84. PubMed ID: 20518604
    [Abstract] [Full Text] [Related]

  • 16. Normal levels of cerebrospinal fluid hypocretin-1 and daytime sleepiness during attacks of relapsing-remitting multiple sclerosis and monosymptomatic optic neuritis.
    Knudsen S, Jennum PJ, Korsholm K, Sheikh SP, Gammeltoft S, Frederiksen JL.
    Mult Scler; 2008 Jul 23; 14(6):734-8. PubMed ID: 18505777
    [Abstract] [Full Text] [Related]

  • 17. [Neurophysiological examinations in narcolepsy].
    Wierzbicka A, Wichniak A, Czasak K, Musińska I, Jakubczyk T, Sek A, Jernajczyk W.
    Przegl Lek; 2010 Jul 23; 67(9):726-8. PubMed ID: 21387813
    [Abstract] [Full Text] [Related]

  • 18. Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia.
    Compta Y, Santamaria J, Ratti L, Tolosa E, Iranzo A, Muñoz E, Valldeoriola F, Casamitjana R, Ríos J, Marti MJ.
    Brain; 2009 Dec 23; 132(Pt 12):3308-17. PubMed ID: 19858078
    [Abstract] [Full Text] [Related]

  • 19. Hypersomnolence and increased REM sleep with low cerebrospinal fluid hypocretin level in a patient after removal of craniopharyngioma.
    Tachibana N, Taniike M, Okinaga T, Ripley B, Mignot E, Nishino S.
    Sleep Med; 2005 Nov 23; 6(6):567-9. PubMed ID: 16084764
    [Abstract] [Full Text] [Related]

  • 20. Hypersomnia and low cerebrospinal fluid hypocretin levels in acute disseminated encephalomyelitis.
    Yoshikawa S, Suzuki S, Kanbayashi T, Nishino S, Tamai H.
    Pediatr Neurol; 2004 Nov 23; 31(5):367-70. PubMed ID: 15519122
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.